American chemical industry news

• 

  20 November 2025

  ORLEN Group Reports Record Q3 2025 Profit and Investment

  ORLEN's Q3 2025 saw high investment in energy security, record dividends, and growth in renewable capacity, with strong performance across all segments despite challenging conditions.
• 

  19 November 2025

  Terumo Aortic Launches Fenestrated TREO® IDE Study in US

  The study evaluates endovascular repair of aortic aneurysms using the Fenestrated TREO® System, enrolling 210 patients across 45 US sites, with a 5-year follow-up.
• 

  19 November 2025

  Aramco Announces $30bn in New US Agreements

  Aramco's new agreements focus on LNG, financial services, advanced materials, and procurement, enhancing strategic growth and US partnerships.
• 

  19 November 2025

  Lilly to Open Gateway Labs in Philadelphia

  New site in Philadelphia will provide lab space and support for early-stage biotech firms, enhancing Lilly's presence in key innovation hubs.
• 

  19 November 2025

  Merck Reports Positive Phase 3 Trial Results for HIV-1 Treatment DOR/ISL

  DOR/ISL shows non-inferiority to BIC/FTC/TAF in HIV-1 treatment-naïve adults, meeting efficacy and safety goals. Detailed findings to be presented at a future scientific congress.
• 

  19 November 2025

  INEOS Invests €250m in Lavera with French Government Support

  The investment aims to modernize Lavera, cut emissions, and secure jobs, with French State backing. High energy costs threaten European industry competitiveness.

• 

  18 November 2025

  Braskem and TE Connectivity Collaborate on Bio-Based Heat Shrink Tubing Innovation

  Bio-based materials reduce emissions in heat shrink tubing, meeting global standards and supporting sustainable electronics manufacturing.
• 

  18 November 2025

  Terumo BCT and University of Chicago Achieve Automated 3-in-1 TCR-T Manufacturing

  Automated TCR-T cell therapy manufacturing on Quantum Flex streamlines processes, enhancing speed, consistency, and scalability for clinical and commercial applications.
• 

  18 November 2025

  Genmab's EPKINLY Combination Approved by FDA for Relapsed Follicular Lymphoma

  EPKINLY + R² shows superior progression-free survival and response rates in Phase 3 trial for relapsed follicular lymphoma, with a consistent safety profile.
• 

  18 November 2025

  Merck's WINREVAIR Achieves Primary Endpoint in Phase 2 Study for Pulmonary Hypertension

  WINREVAIR reduced pulmonary vascular resistance in Phase 2 CADENCE study, supporting Phase 3 development for treating pulmonary hypertension due to heart failure with preserved ejection fraction.
• 

  18 November 2025

  Brenntag Acquires Chem Tech Services in North America

  The acquisition enhances Brenntag's energy solutions in the Permian Basin, integrating Chem Tech into Coastal Chemical to strengthen its oil and gas market presence.
• 

  17 November 2025

  BASF and ExxonMobil Collaborate on Methane Pyrolysis for Low-Emission Hydrogen

  A demonstration plant in Texas will validate methane pyrolysis technology, producing low-emission hydrogen and solid carbon, enhancing industrial hydrogen solutions.
• 

  17 November 2025

  ENGIE Secures Low-Carbon Energy for Tech Giants

  Tech companies are securing energy supply and reducing carbon footprints through renewable PPAs, ensuring price stability and supporting rapid data center growth.
• 

  17 November 2025

  Merus and Halozyme Collaborate on Subcutaneous Petosemtamab Development

  Merus licenses Halozyme's ENHANZE® for subcutaneous petosemtamab, targeting solid tumors. Agreement includes upfront, milestone payments, and royalties.
• 

  17 November 2025

  Siemens Boosts Energy Efficiency Modeling with Setmetrics Technology

  Siemens' Brightly Software enhances energy modeling, reducing design effort by 80%, aiding sustainability in real estate, education, and healthcare sectors.
• 

  14 November 2025

  PureCycle and Churchill Container Win U.S. Plastics Pact Award for PCR Content

  The Run It Back™ line, using PureFive™ resin, won for its 100% recycled content, first used by the Cleveland Browns, highlighting a shift towards circular solutions in packaging.
• 

  14 November 2025

  Merck Acquires Cidara Therapeutics, Adds Antiviral to Portfolio

  Merck acquires Cidara for $9.2B, enhancing its pipeline with CD388, a late-phase antiviral for influenza prevention, pending regulatory approvals.
• 

  14 November 2025

  RWE Completes Lafitte Solar Project in Louisiana

  Lafitte Solar delivers 100 MW to Louisiana, creates 150+ jobs, $32M in tax revenue, and supports local biodiversity and agriculture with native vegetation and sheep grazing.
• 

  13 November 2025

  Novo Nordisk: Mikael Dolsten Withdraws Board Candidacy

  Mikael Dolsten won't seek election to the Board due to personal reasons. No replacement will be proposed until the Annual General Meeting in March 2026.
• 

  12 November 2025

  Solvay Secures US Rare Earth Supply with Permag and LCM Deal

  The partnership ensures a stable Samarium supply for high-performance magnets, supporting sustainable and secure supply chains for critical materials in various industries.
• 

  12 November 2025

  Terumo BCT and Santersus Partner on Sepsis Apheresis Technology

  The partnership aims to enhance sepsis treatment by removing NETs from blood, potentially reducing mortality and ICU stays.
• 

  12 November 2025

  Solvay and Noveon Partner for Rare Earth Supply

  Starting 2026, rare earth oxides will be supplied to strengthen U.S. magnet supply chain, focusing on sustainability and domestic production amid rising demand.
• 

  12 November 2025

  TotalEnergies to Supply Google Data Centers with Renewable Power for 15 Years

  TotalEnergies' Montpelier solar farm in Ohio will supply 1.5 TWh of renewable electricity to support Google's data centers, aligning with both companies' clean energy strategies.
• 

  12 November 2025

  Chevron Plans for 10% Annual Cash Flow Growth

  Chevron targets 10% annual EPS growth, reduces capex to $18-$21B, and plans $10-$20B share repurchases yearly. Focus on AI power solutions and new energies for long-term shareholder value.
• 

  12 November 2025

  SDC Technologies Expands R&D and Manufacturing in the US

  SDC relocates to Rancho Santa Margarita, enhancing R&D and manufacturing for coating materials and lens equipment, aiming for growth in vision care materials. Completion by October 2026.
• 

  12 November 2025

  RWE Reports Strong Q3 2025 Financials, Continues Growth Investments

  Adjusted EBITDA hits €3.5B; net income €1.3B. Renewable capacity grows to 38.7 GW. 2025 guidance and 2030 targets confirmed.
• 

  11 November 2025

  Ercros Reports EUR 4M EBITDA, EUR 41M Losses

  Weak demand, high energy costs, and competition impact results. Cost reduction plan on track. Solid liquidity. Awaiting EU support. Bondalti takeover bid approved with conditions.
• 

  11 November 2025

  EU Approves Joint Ventures in Energy and Data Sectors

  The European Commission approved joint ventures for CO2 projects, data centers, and port energy services, citing no competition concerns.
• 

  10 November 2025

  Trinseo's U.S. Sites Achieve OCS Blue Verification

  Midland and Louisville sites meet OCS Blue standards, preventing plastic resin loss through rigorous controls, training, and audits, reinforcing sustainability and operational excellence.
• 

  10 November 2025

  Boehringer Ingelheim's Zongertinib Receives FDA Priority Voucher for HER2-Mutant NSCLC

  Zongertinib gains FDA's Priority Voucher, expediting review for HER2-mutant NSCLC treatment. A supplemental New Drug Application is planned for first-line use.